ArticleBMC cancer2026

Conjoining cell reprogramming and mass spectrometry to identify the proteomic variations in the reprogrammed bladder cancer cells: finding cues of normalisation.

Banu Iskender et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.